CLAIMS RELATED TO USE OF INTELLECTUAL PROPERTY. Lilly represents and warrants that there are no pending, or to Lilly's knowledge as of the Effective Date, threatened claims against Lilly or its Affiliates asserting that any of the Intellectual Property infringes or violates the rights of Third Persons or that NeoSan, by practicing under the Intellectual Property in conducting the Activities in the United States as of the Closing Date, would violate any of the intellectual property rights of any Third Person.
Appears in 4 contracts
Samples: Assignment, Transfer and Assumption Agreement (Xanodyne Pharmaceuticals Inc), Assignment, Transfer and Assumption Agreement (Aaipharma Inc), Assignment, Transfer and Assumption Agreement (Xanodyne Pharmaceuticals Inc)
